HIV Protease Inhibitors

Antiviral Agents
Impact of Human Immunodeficiency Virus Type 1 Subtype C on Drug Resistance Mutations in Patients from Botswana Failing a Nelfinavir-Containing Regimen
Florence Doualla-Bell, Ava Avalos, Tendani Gaolathe, Madisa Mine, Simani Gaseitsiwe, Ndwapi Ndwapi, Vladimir A. Novitsky, Bluma Brenner, Maureen Oliveira, Daniella Moisi, Howard Moffat, Ibou Thior, Max Essex, Mark A. Wainberg
Clinical Therapeutics
Pregnancy-Related Effects on Nelfinavir-M8 Pharmacokinetics: a Population Study with 133 Women
Déborah Hirt, Jean-Marc Treluyer, Vincent Jullien, Ghislaine Firtion, Hélène Chappuy, Elisabeth Rey, Gérard Pons, Laurent Mandelbrot, Saïk Urien
Clinical Therapeutics
Ritonavir Increases Plasma Amprenavir (APV) Exposure to a Similar Extent when Coadministered with either Fosamprenavir or APV
Mary B. Wire, Katherine L. Baker, Lori S. Jones, Mark J. Shelton, Yu Lou, Greg J. Thomas, M. Michelle Berrey
Antiviral Agents
Substrate Envelope and Drug Resistance: Crystal Structure of RO1 in Complex with Wild-Type Human Immunodeficiency Virus Type 1 Protease
Moses Prabu-Jeyabalan, Nancy M. King, Ellen A. Nalivaika, Gabrielle Heilek-Snyder, Nick Cammack, Celia A. Schiffer
Antiviral Agents
In Vitro Development of Resistance to Human Immunodeficiency Virus Protease Inhibitor GW640385
P. J. Yates, R. Hazen, M. St. Clair, L. Boone, M. Tisdale, R. C. Elston
Clinical Therapeutics
Pharmacokinetic and Safety Evaluation of High-Dose Combinations of Fosamprenavir and Ritonavir
Mark J. Shelton, Mary Beth Wire, Yu Lou, Brigette Adamkiewicz, Sherene S. Min
Clinical Therapeutics
Age-Related Effects on Nelfinavir and M8 Pharmacokinetics: a Population Study with 182 Children
Déborah Hirt, Saïk Urien, Vincent Jullien, Ghislaine Firtion, Elisabeth Rey, Gérard Pons, Stéphane Blanche, Jean-Marc Treluyer
Antiviral Agents
Practical Preclinical Model for Assessing the Potential for Unconjugated Hyperbilirubinemia Produced by Human Immunodeficiency Virus Protease Inhibitors
Dale J. Kempf, Jeffrey F. Waring, David C. Morfitt, Paige Werner, Brian Ebert, Michael Mitten, Bach Nguyen, John T. Randolph, David A. DeGoey, Larry L. Klein, Kennan Marsh
Susceptibility
Potencies of Human Immunodeficiency Virus Protease Inhibitors In Vitro against Plasmodium falciparum and In Vivo against Murine Malaria
Katherine T. Andrews, David P. Fairlie, Praveen K. Madala, John Ray, David M. Wyatt, Petrina M. Hilton, Lewis A. Melville, Lynette Beattie, Donald L. Gardiner, Robert C. Reid, Martin J. Stoermer, Tina Skinner-Adams, Colin Berry, James S. McCarthy
Antiviral Agents
Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent
Joke Snoeck, Rami Kantor, Robert W. Shafer, Kristel Van Laethem, Koen Deforche, Ana Patricia Carvalho, Brian Wynhoven, Marcelo A. Soares, Patricia Cane, John Clarke, Candice Pillay, Sunee Sirivichayakul, Koya Ariyoshi, Africa Holguin, Hagit Rudich, Rosangela Rodrigues, Maria Belen Bouzas, Françoise Brun-Vézinet, Caroline Reid, Pedro Cahn, Luis Fernando Brigido, Zehava Grossman, Vincent Soriano, Wataru Sugiura, Praphan Phanuphak, Lynn Morris, Jonathan Weber, Deenan Pillay, Amilcar Tanuri, Richard P. Harrigan, Ricardo Camacho, Jonathan M. Schapiro, David Katzenstein, Anne-Mieke Vandamme

Main menu

User menu

Search

HIV Protease Inhibitors

Pages